Acumen Pharmaceuticals, Inc. Share Price
Equities
ABOS
US00509G2093
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.345 USD | +5.52% | +6.07% | -13.54% |
04-04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
04-04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 190M 15.16B |
---|---|---|---|---|---|
Net income 2024 * | -68M -5.41B | Net income 2025 * | -93M -7.4B | EV / Sales 2024 * | - |
Net cash position 2024 * | 121M 9.62B | Net cash position 2025 * | 258M 20.5B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.6
x | P/E ratio 2025 * |
-2
x | Employees | 52 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.87% |
Latest transcript on Acumen Pharmaceuticals, Inc.
1 day | +5.52% | ||
1 week | +6.07% | ||
Current month | -18.02% | ||
1 month | -17.21% | ||
3 months | -2.92% | ||
6 months | +50.57% | ||
Current year | -13.54% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 31/03/06 |
Jim Doherty
PSD | President | 56 | 01-31 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 30/04/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 31/03/06 |
Director/Board Member | 55 | 31/03/22 | |
Jeffrey Ives
BRD | Director/Board Member | 73 | 30/04/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 3.317 | +4.65% | 127 739 |
26/04/24 | 3.17 | -0.63% | 140,701 |
25/04/24 | 3.19 | +0.31% | 167,647 |
24/04/24 | 3.18 | +0.63% | 152,249 |
23/04/24 | 3.16 | +0.96% | 270,690 |
Delayed Quote Nasdaq, April 29, 2024 at 05:16 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.54% | 190M | |
+2.66% | 42.75B | |
+47.70% | 41.61B | |
+12.19% | 41.34B | |
-8.83% | 26.59B | |
+7.99% | 25.49B | |
-22.90% | 18.12B | |
+31.39% | 12.24B | |
-1.40% | 11.76B | |
+8.54% | 11B |
- Stock Market
- Equities
- ABOS Stock